Meta Pixel

News and Announcements

SUDA Granted Canadian Patent for SUD-002

  • Published April 12, 2016 3:34PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

12th April 2016, ASX Announcement

SUDA Ltd (ASX: SUD), a leader in oro-mucosal drug deliver, is pleased to announce that the Canadian Intellectual Property Office has issued Canada Patent number 2,673,049, covering the Company’s novel oral spray of ondansetron (SUD-002). The patent is entitled “Stable Anti-nausea Oral Spray Formulations and Methods” and has an expiry date of  21 December 2017.

This is the second patent to be issued in Canada for SUDA’s SUD-002 oral spray to treat nausea and vomiting induced by chemotherapy, radiotherapy and also in post-operative settings. It is part of the broad intellectual property portfolio acquired by SUDA from NovaDel in 2013. The patent has been granted or is pending in other major jurisdictions.

To view the full article please click on the button below.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now